dc.contributor.author |
Loutrari, H |
en |
dc.contributor.author |
Skouridou, V |
en |
dc.contributor.author |
Kolisis, FN |
en |
dc.contributor.author |
Roussos, C |
en |
dc.contributor.author |
Papapetropoulos, A |
en |
dc.date.accessioned |
2014-03-01T02:49:53Z |
|
dc.date.available |
2014-03-01T02:49:53Z |
|
dc.date.issued |
2004 |
en |
dc.identifier.issn |
10116583 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/34764 |
|
dc.relation.uri |
http://www.scopus.com/inward/record.url?eid=2-s2.0-1542350112&partnerID=40&md5=4b5f02c3edfd1c45a02f466e209458c0 |
en |
dc.subject.other |
angiogenic factor |
en |
dc.subject.other |
angiopoietin 2 |
en |
dc.subject.other |
mitogen activated protein kinase 1 |
en |
dc.subject.other |
perillyl alcohol |
en |
dc.subject.other |
phorbol 13 acetate 12 myristate |
en |
dc.subject.other |
protein kinase B |
en |
dc.subject.other |
vasculotropin |
en |
dc.subject.other |
angiogenesis |
en |
dc.subject.other |
animal cell |
en |
dc.subject.other |
apoptosis |
en |
dc.subject.other |
cattle |
en |
dc.subject.other |
cell proliferation |
en |
dc.subject.other |
cell strain K 562 |
en |
dc.subject.other |
cell survival |
en |
dc.subject.other |
conference paper |
en |
dc.subject.other |
endothelium cell |
en |
dc.subject.other |
enzyme phosphorylation |
en |
dc.subject.other |
human |
en |
dc.subject.other |
human cell |
en |
dc.subject.other |
nonhuman |
en |
dc.subject.other |
protein expression |
en |
dc.title |
Perillyl Alcohol Attenuates in vitro Angiogenesis, Modulates Angiogenic Factor Production and Inhibits Cell Proliferation and Survival in Endothelial and Tumour Cells |
en |
heal.type |
conferenceItem |
en |
heal.publicationDate |
2004 |
en |
heal.abstract |
Anti-angiogenic therapy is one of the most promising approaches to control cancer. In this work we studied the effects of perillyl alcohol (POH), a dietary monoterpene with in vivo anti-cancer activity on in vitro angiogenesis, expression of angiogenic ligands and cell proliferation/apoptosis using endothelial and tumour cells. We have shown that POH attenuates the capillary-like organization of cultured endothelial cells, decreases the expression of vascular endothelial growth factor (VEGF) by cancer cells, increases the expression of Angiopoietin 2 (Ang2) by endothelial cells and inhibits cell proliferation and survival in both cell types. We have also demonstrated that POH inhibits the phosphorylation of two key signaling molecules: Akt in endothelial cells and Erk1/2 in cancer cells. |
en |
heal.journalName |
Review of Clinical Pharmacology and Pharmacokinetics, International Edition |
en |
dc.identifier.volume |
18 |
en |
dc.identifier.issue |
1 |
en |
dc.identifier.spage |
30 |
en |
dc.identifier.epage |
32 |
en |